FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to dermatology and can be used for treatment of psoriasis. For this purpose, on skin affected by psoriasis composition, containing efficient amount of clobetasol propionate is sprayed daily for not less than 4 weeks. Preferable composition includes clobetasol propionate, ethyl alcohol, isopropyl myristate and anionic surfactant.
EFFECT: method ensures increase of therapy efficiency and safety in case of long-term application of clobetasol propionate for treatment of psoriasis.
2 tbl, 5 dwg, 23 cl
| Title | Year | Author | Number |
|---|---|---|---|
| TOPICAL COMPOSITIONS CONTAINING CORTICOSTEROID | 2016 |
|
RU2690659C2 |
| PHARMACEUTICAL FORMULATIONS CONTAINING CORTICOSTEROIDS FOR TOPICAL APPLICATION | 2011 |
|
RU2568598C2 |
| PHARMACEUTICAL COMPOSITION FOR LOCAL APPLICATION CONTAINING COMBINATION OF FUSIDIC ACID AND CORTICOSTEROID | 2008 |
|
RU2470645C2 |
| ANTIPSORIATIC COSMETIC COMPOSITION IN A GEL FORM | 2020 |
|
RU2742411C1 |
| METHOD OF TREATING PALMAR-PLANTAR ERYTHRODYSESTHESIA | 2018 |
|
RU2722396C2 |
| DELIVERY SYSTEM IN THE FORM OF GEL FOR LOCAL APPLICATION | 2001 |
|
RU2251410C2 |
| SPRAYABLE TOPICAL CARRIER AND COMPOSITION CONTAINING PHOSPHATIDYLCHOLINE | 2014 |
|
RU2699651C1 |
| METHOD FOR TREATING GUTTATE PSORIASIS | 2018 |
|
RU2697415C1 |
| METHOD FOR FORMING EXPERIMENTAL MODEL OF CHRONIC IMIQUIMOD-INDUCED PSORIASIS-LIKE DERMATITIS IN MICE | 2023 |
|
RU2820279C1 |
| STABILISED COMPOSITION FOR TREATING PSORIASIS | 2009 |
|
RU2526162C2 |
